Succeeding In Value-Based Care With A Next-Gen Revenue Cycle

January 17, 2020

Value-based reimbursement (VBR) models are becoming more common. Success under these models depends on showing positive improvement in key metrics, but providers often struggle to accurately report the quality of care provided. A next-generation revenue cycle that combines clinically aware artificial intelligence (AI) with an unmatched foundation of evidence-based medical research and knowledge provides the transparency necessary to both accurately report care quality and directly influence the patient satisfaction quality metric. This paper reviews how a well-tuned revenue cycle can help hospitals succeed with value-based contracts, earning appropriate incentives and avoiding penalties.

Spotlight

UTHealth

The University of Texas Health Science Center at Houston (UTHealth), primarily a graduate education university, educates the largest number of health care professionals in Texas.

OTHER WHITEPAPERS
news image

In collaboration with Duke Kunshan University GlobalHealth Research Center

whitePaper | November 15, 2022

The COVID-19 pandemic has exposed the vulnerabilities of global and national health systems. Already-struggling healthcare systems have shifted their resources to the pandemic response

Read More
news image

Healthcare Marketing Trends for 2022

whitePaper | July 7, 2022

Between the impact of the COVID-19 pandemic, the progressive shift to a cookieless world, and additional factors turning digital marketing

Read More
news image

Open Knowledge in Digital Health

whitePaper | June 16, 2021

Unless you‘ve been off-planet for the last few years, you’ll know that digital technology has revolutionised healthcare. Come to think of it, even those tracked with human telemetry on the International Space Station (ISS) have benefited from these revolutionary advances. So perhaps not.

Read More
news image

Future of medical science

whitePaper | May 14, 2022

Medical science is currently being transformed by scientific discoveries that will dramatically advance the way we diagnose and treat different diseases.

Read More
news image

Using Clinical Trial Sites’Input to Select the Right Capabilities when Decentralizing Clinical Trials

whitePaper | March 22, 2023

The COVID-19 pandemic has renewed emphasis on innovations to support clinical trial operations. Traditional sites including hospitals and private practices were forced during the height of the pandemic to find novel ways to continue patient care.

Read More
news image

The cultural shift to smart manufacturing in the medical device industry

whitePaper | February 22, 2023

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier.

Read More

Spotlight

UTHealth

The University of Texas Health Science Center at Houston (UTHealth), primarily a graduate education university, educates the largest number of health care professionals in Texas.

Events